South Africa suspends use of AstraZeneca vaccine after trial showing limited protection


JOHANNESBURG (Reuters) – South Africa will suspend use of the AstraZeneca vaccine in its immunisation programme while scientists advise on the best way to proceed, Health Minister Zweli Mkhize said on Sunday.


Mkhize was speaking after trial data showed the AstraZeneca vaccine offered only limited protection against mild disease caused by the 501Y.V2 coronavirus variant first identified in South Africa.

(Reporting by Alexander Winning and Olivia Kumwenda-Mtambo)

Source link


Articles You May Like

The day before elections, Peru marks record COVID-19 deaths
Turkey, Libya committed to eastern Mediterranean maritime accord
The sudden visit to COVID victims’ families that sparked Jordan’s royal rift
People can now think about summer vacations, UK minister says
English shops and pub gardens reopen in ‘major step’ to freedom